Drug Science company information, Employees & Contact Information

Help us raise funds for people who use drugs Drug Science

Royal College of Psychiatrists call for more research into psychedelics for medical use Drug Science

Response to ACMD Ketamine Harms Assessment Drug Science

We Out Here Festival 2025 - Psychedelics and Connectedness Drug Science

Easing End-of-Life Distress: Should Psychedelic Therapy Be Part of Palliative Care in the UK? Drug Science

A lexicon for psychedelic research and treatment Drug Science

Germany Pioneers Compassionate Psilocybin Access for Treatment-Resistant Depression in EU First Drug Science

Medicinal Cannabis Use Among People with Obsessive Compulsive Disorder: Changes in Quality of Life After Three Months Drug Science

Substance Abuse Among Healthcare Students: The Interplay of Stress, Knowledge, and Awareness Drug Science

Controlled Substances, Controlled People: How Drug Laws Reinforce Colonial Power Structures Drug Science

UK Government supports ACMD plan to enable research with schedule 1 medicines such as psilocybin and MDMA Drug Science

Amanda Feilding Drug Science

London Drugs Commission’s Recommendations: A Step Forward in Cannabis Policy Drug Science

Psychedelics and Nature Connectedness: Potential for Restoring a Lost Relationship Drug Science

Ukraine Opens the Door to Psychedelic Research: A First Legal Framework Emerges Drug Science

Cambridge officially launches research group to advance psychedelic-assisted therapy for mental health Drug Science

What can Boomtown 2025 teach us about responding to drug use? Drug Science

Clarifying the legal landscape of psilocybin regulation: A medico-legal perspective Drug Science

Psychedelic Training UK Drug Science

Patterns of recreational substance use, help seeking and harm reduction among UK music festival attendees Drug Science

Reflections on ‘Psychedelics – a national discussion’, Aotearoa, New Zealand Drug Science

Drug Information Drug Science

Allaying the fears: MDMA with therapy is a medicine Drug Science

What is Kava? Drug Science

Medical Cannabis Education Drug Science

Drug Science and University College London Collaboration: Advancing MDMA-Assisted Therapy Drug Science

Drug Science submits evidence to the ACMD Nitrous Oxide Review Drug Science

Education Drug Science

Cookie Policy Drug Science

Irresponsible publicity related to an unpublished vaping study Drug Science

Drug Science’s medical cannabis patient registry (T21) to continue for a fourth year Drug Science

Consultancy Drug Science

Community Drug Science

Drug Science launches Working Group on Psychedelics Drug Science

How can we prepare psychiatry for a psychedelic future? Drug Science

Project Twenty21 in 2022: A Message for Patients Drug Science

Parliamentary briefing on tackling the misuse of Nitrous Oxide Drug Science

Doubt it not, MDMA is a medicine Drug Science

“Are they simply scared of cannabis?” Drug Science

Overdose Prevention Centres, Safe Consumption Sites, and Drug Consumption Rooms: A Rapid Evidence Review Drug Science

The Drug Science podcast returns with two new co-hosts! Drug Science

Drug Science to launch first study to directly test molecular neuroplasticity effects of DMT in humans Drug Science

Building a Career in Drug Science Drug Science

Medical Psychedelics Working Group Drug Science

Medical Cannabis Working Group Drug Science

An exploration of medical professionals’ attitudes, perceived knowledge and concerns around medical cannabis in the United Kingdom Drug Science

Teaching Children about Vaping Drug Science

Medical Cannabis Improves Patients’ Quality of Life More Than Any Other Treatment For Chronic Neuropathic Pain Drug Science

Grow Pharma joins T21 Drug Science

Putting UK Drug Policy into Focus Drug Science

Are Psychedelics Legal in the Netherlands? Drug Science

Street Drugs Discussions Drug Science

Donate Drug Science

The Post COVID cathinone hydra Drug Science

YouGov Results - Is the UK Ready to Reschedule Psilocybin? Drug Science

Drug Science submission to the WHO enquiry on vaping Drug Science

Psilocybin shows promise in supporting symptoms of Premenstrual Dysphoric Disorder Drug Science

Report of the Dutch State Committee on MDMA: A summary of findings and recommendations Drug Science

Medical cannabis could save NHS £4 billion each year Drug Science

The end of the pilot stage: The long and winding road to drug checking in the UK Drug Science

“SIZE MATTERS”: High strength ecstasy pills are back, so harm reduction communications need to adapt Drug Science

UK’s largest medical cannabis study announces new industry partners Drug Science

The Case for Overdose Prevention Centres in the UK - An Evidence-based approach Drug Science

The UK needs common sense about ketamine Drug Science

3 Years Since the UK Legalised Medical Cannabis, and Only 3 NHS Prescriptions Drug Science

THCv - an abject cop-out from the ACMD, another research opportunity for the UK lost Drug Science

In defence of the decriminalisation of drug possession in the UK Drug Science

Schedule 1 Barriers to Research in the UK: An In-depth Qualitative Analysis Drug Science

MCDA Comparison of Drug and Alcohol Harms in the UK Drug Science